Status:
COMPLETED
Secondary Prevention of Osteoporosis
Lead Sponsor:
Hebrew SeniorLife
Collaborating Sponsors:
National Institute on Aging (NIA)
Merck Sharp & Dohme LLC
Conditions:
Osteoporosis
Eligibility:
All Genders
65+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to develop and implement an evidence based protocol for the secondary prevention of osteoporotic fractures and falls, and to determine how compliance with this interventio...
Detailed Description
Following a fracture, few persons are screened or treated for osteoporosis (Feldstein et al). It is not surprising, then, that the risk of future osteoporotic fractures remains high. Although little d...
Eligibility Criteria
Inclusion
- Admitted to rehab unit with the primary or secondary diagnosis of fracture
- English speaking
- Cognitively able to provide consent or health care proxy available and willing to provide consent
- Willing to cooperate
Exclusion
- Pathologic or periprosthetic fractures
- Creatinine clearance less than 15ml/minute
- Severe hypocalcemia
- Esophageal stricture or achalasia
- Taking other treatment for osteoporosis besides calcium or vitamin D in the past 6-months
- History of kidney stones in the past 6-months
Key Trial Info
Start Date :
February 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2008
Estimated Enrollment :
29 Patients enrolled
Trial Details
Trial ID
NCT00421343
Start Date
February 1 2007
End Date
June 1 2008
Last Update
February 5 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hebrew SeniorLife
Boston, Massachusetts, United States, 02131